People

David Roblin
David Roblin is Chief Executive Officer of Relation, leading AI-assisted drug discovery and development. He previously led European R&D at Pfizer and held senior scientific-translation and executive roles at the Francis Crick Institute. The company appointed him CEO in June 2022.
Roles
Relation Therapeutics
CurrentChief Executive Officer
Relation Therapeutics
CurrentBoard Member